Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Acute Nausea and Vomitting Treatment
1.3.3 Delayed Nausea and Vomitting Treatment
1.3.4 Anticipatory Nausea and Vomitting Treatment
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Perspective (2018-2029)
2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Growth Trends by Region
2.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Region (2018-2024)
2.2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Region (2024-2029)
2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Dynamics
2.3.1 Chemotheraphy-induced Nausea and Vomitting Treatment Industry Trends
2.3.2 Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
2.3.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
2.3.4 Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Revenue
3.1.1 Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Revenue (2018-2024)
3.1.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue
3.4 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio
3.4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2022
3.5 Chemotheraphy-induced Nausea and Vomitting Treatment Key Players Head office and Area Served
3.6 Key Players Chemotheraphy-induced Nausea and Vomitting Treatment Product Solution and Service
3.7 Date of Enter into Chemotheraphy-induced Nausea and Vomitting Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Type
4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Type (2018-2024)
4.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2024-2029)
5 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Application
5.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Application (2018-2024)
5.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
6.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024)
6.4 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
7.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024)
7.4 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
8.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
9.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024)
9.4 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2018-2029)
10.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Helsinn
11.2.1 Helsinn Company Detail
11.2.2 Helsinn Business Overview
11.2.3 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.2.4 Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.2.5 Helsinn Recent Development
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Company Detail
11.3.2 Heron Therapeutics Business Overview
11.3.3 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.3.4 Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.3.5 Heron Therapeutics Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Detail
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.4.4 Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.4.5 Merck & Co Recent Development
11.5 Tesaro
11.5.1 Tesaro Company Detail
11.5.2 Tesaro Business Overview
11.5.3 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.5.4 Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.5.5 Tesaro Recent Development
11.6 Acacia Pharma
11.6.1 Acacia Pharma Company Detail
11.6.2 Acacia Pharma Business Overview
11.6.3 Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.6.4 Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.6.5 Acacia Pharma Recent Development
11.7 Aphios
11.7.1 Aphios Company Detail
11.7.2 Aphios Business Overview
11.7.3 Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.7.4 Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.7.5 Aphios Recent Development
11.8 Barr Laboratories
11.8.1 Barr Laboratories Company Detail
11.8.2 Barr Laboratories Business Overview
11.8.3 Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.8.4 Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.8.5 Barr Laboratories Recent Development
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Detail
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.9.4 Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.9.5 Baxter Healthcare Recent Development
11.10 Eisai
11.10.1 Eisai Company Detail
11.10.2 Eisai Business Overview
11.10.3 Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.10.4 Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.10.5 Eisai Recent Development
11.11 Especificos Stendhal
11.11.1 Especificos Stendhal Company Detail
11.11.2 Especificos Stendhal Business Overview
11.11.3 Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.11.4 Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.11.5 Especificos Stendhal Recent Development
11.12 F.Hoffmann La Roche
11.12.1 F.Hoffmann La Roche Company Detail
11.12.2 F.Hoffmann La Roche Business Overview
11.12.3 F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.12.4 F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.12.5 F.Hoffmann La Roche Recent Development
11.13 Mundipharma
11.13.1 Mundipharma Company Detail
11.13.2 Mundipharma Business Overview
11.13.3 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.13.4 Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.13.5 Mundipharma Recent Development
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Detail
11.14.2 Mylan Pharmaceuticals Business Overview
11.14.3 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.14.4 Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.14.5 Mylan Pharmaceuticals Recent Development
11.15 OPKO Health
11.15.1 OPKO Health Company Detail
11.15.2 OPKO Health Business Overview
11.15.3 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.15.4 OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.15.5 OPKO Health Recent Development
11.16 Orchid Healthcare
11.16.1 Orchid Healthcare Company Detail
11.16.2 Orchid Healthcare Business Overview
11.16.3 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.16.4 Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
11.16.5 Orchid Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of 5-HT3 Inhibitors
Table 3. Key Players of NK1 Inhibitors
Table 4. Key Players of Others
Table 5. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2018-2024)
Table 9. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2024-2029)
Table 11. Chemotheraphy-induced Nausea and Vomitting Treatment Market Trends
Table 12. Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
Table 13. Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
Table 14. Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
Table 15. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players (2018-2024)
Table 17. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2022)
Table 18. Ranking of Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chemotheraphy-induced Nausea and Vomitting Treatment Product Solution and Service
Table 22. Date of Enter into Chemotheraphy-induced Nausea and Vomitting Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2018-2024)
Table 26. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Application (2018-2024)
Table 30. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 50. GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Helsinn Company Detail
Table 53. Helsinn Business Overview
Table 54. Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 55. Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 56. Helsinn Recent Development
Table 57. Heron Therapeutics Company Detail
Table 58. Heron Therapeutics Business Overview
Table 59. Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 60. Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 61. Heron Therapeutics Recent Development
Table 62. Merck & Co Company Detail
Table 63. Merck & Co Business Overview
Table 64. Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 65. Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 66. Merck & Co Recent Development
Table 67. Tesaro Company Detail
Table 68. Tesaro Business Overview
Table 69. Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 70. Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 71. Tesaro Recent Development
Table 72. Acacia Pharma Company Detail
Table 73. Acacia Pharma Business Overview
Table 74. Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 75. Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 76. Acacia Pharma Recent Development
Table 77. Aphios Company Detail
Table 78. Aphios Business Overview
Table 79. Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 80. Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 81. Aphios Recent Development
Table 82. Barr Laboratories Company Detail
Table 83. Barr Laboratories Business Overview
Table 84. Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 85. Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 86. Barr Laboratories Recent Development
Table 87. Baxter Healthcare Company Detail
Table 88. Baxter Healthcare Business Overview
Table 89. Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 90. Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 91. Baxter Healthcare Recent Development
Table 92. Eisai Company Detail
Table 93. Eisai Business Overview
Table 94. Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 95. Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 96. Eisai Recent Development
Table 97. Especificos Stendhal Company Detail
Table 98. Especificos Stendhal Business Overview
Table 99. Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 100. Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 101. Especificos Stendhal Recent Development
Table 102. F.Hoffmann La Roche Company Detail
Table 103. F.Hoffmann La Roche Business Overview
Table 104. F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 105. F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 106. F.Hoffmann La Roche Recent Development
Table 107. Mundipharma Company Detail
Table 108. Mundipharma Business Overview
Table 109. Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 110. Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 111. Mundipharma Recent Development
Table 112. Mylan Pharmaceuticals Company Detail
Table 113. Mylan Pharmaceuticals Business Overview
Table 114. Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 115. Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 116. Mylan Pharmaceuticals Recent Development
Table 117. OPKO Health Company Detail
Table 118. OPKO Health Business Overview
Table 119. OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 120. OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 121. OPKO Health Recent Development
Table 122. Orchid Healthcare Company Detail
Table 123. Orchid Healthcare Business Overview
Table 124. Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
Table 125. Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024) & (US$ Million)
Table 126. Orchid Healthcare Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type: 2022 VS 2029
Figure 3. 5-HT3 Inhibitors Features
Figure 4. NK1 Inhibitors Features
Figure 5. Others Features
Figure 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application: 2022 VS 2029
Figure 8. Acute Nausea and Vomitting Treatment Case Studies
Figure 9. Delayed Nausea and Vomitting Treatment Case Studies
Figure 10. Anticipatory Nausea and Vomitting Treatment Case Studies
Figure 11. Chemotheraphy-induced Nausea and Vomitting Treatment Report Years Considered
Figure 12. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players in 2022
Figure 16. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2022
Figure 18. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2018-2029)
Figure 20. United States Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2018-2029)
Figure 24. Germany Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2018-2029)
Figure 32. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. GlaxoSmithKline Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 47. Helsinn Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 48. Heron Therapeutics Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 49. Merck & Co Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 50. Tesaro Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 51. Acacia Pharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 52. Aphios Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 53. Barr Laboratories Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 54. Baxter Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 55. Eisai Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 56. Especificos Stendhal Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 57. F.Hoffmann La Roche Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 58. Mundipharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 59. Mylan Pharmaceuticals Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 60. OPKO Health Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 61. Orchid Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2018-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed